Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Y-mAbs Therapeutics, Inc. (YMAB)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Total revenues  20.820.312.510.810.59.69.011.0
            Revenue growth  92.2%93.1%39.8%-1.4%94.8%-53.7%  
Cost of goods sold  4.62.12.51.11.81.50.60.2
Gross profit  16.118.210.19.78.78.18.410.8
            Gross margin  77.6%89.7%80.3%89.4%82.5%84.8%93.9%98.2%
Selling, general and administrative   [+]11.312.313.623.113.415.114.013.5
Research and development  12.113.422.526.422.928.823.119.8
Other operating expenses     0.1   0.2
EBITDA   [+]-7.0-7.3-25.8-39.8-27.5-35.5-28.6-22.5
            EBITDA margin  -33.7%-36.1%-205.7%-368.2%-262.3%-369.5%-318.6%-205.4%
Depreciation and amortization  0.20.20.20.20.20.30.10.2
EBIT   [+]-7.2-7.5-26.0-39.9-27.7-35.8-28.7-22.7
            EBIT margin  -34.8%-37.0%-207.5%-370.0%-264.1%-372.6%-320.2%-207.4%
Other income (expense), net  1.11.1-1.5-1.2-0.4-1.1-0.2-0.2
Pre-tax income  -6.1-6.4-27.5-41.1-28.1-36.9-28.9-22.9
Income taxes  0.20.00.00.00.00.00.00.0
            Tax rate   0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -6.3-6.4-27.5-41.1-28.1-36.9-28.9-22.9
            Net margin  -30.4%-31.6%-219.6%-380.9%-267.7%-384.4%-321.9%-209.5%
   
Basic EPS   [+]($0.14)($0.15)($0.63)($0.94)($0.64)($0.85)($0.66)($0.53)
Diluted EPS   [+]($0.14)($0.15)($0.63)($0.94)($0.64)($0.85)($0.66)($0.53)
   
Shares outstanding (basic)   [+]43.743.743.743.743.743.243.643.6
Shares outstanding (diluted)   [+]43.743.743.743.743.743.243.643.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy